Mustang Bio Inc (MBIO)
0.3175
-0.03
(-9.39%)
USD |
NASDAQ |
Apr 26, 16:00
0.3159
0.00 (0.00%)
After-Hours: 19:17
Mustang Bio Cash from Investing (TTM): 5.886M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 5.886M |
September 30, 2023 | 5.496M |
June 30, 2023 | -1.346M |
March 31, 2023 | -1.618M |
December 31, 2022 | -2.952M |
September 30, 2022 | -4.009M |
June 30, 2022 | -4.107M |
March 31, 2022 | -6.242M |
December 31, 2021 | -5.366M |
September 30, 2021 | -5.353M |
June 30, 2021 | -5.971M |
March 31, 2021 | -4.344M |
December 31, 2020 | -4.412M |
September 30, 2020 | -4.339M |
June 30, 2020 | -3.63M |
Date | Value |
---|---|
March 31, 2020 | 1.382M |
December 31, 2019 | 13.91M |
September 30, 2019 | 20.00M |
June 30, 2019 | 31.25M |
March 31, 2019 | 24.31M |
December 31, 2018 | 0.557M |
September 30, 2018 | 3.294M |
June 30, 2018 | -22.93M |
March 31, 2018 | -40.43M |
December 31, 2017 | -29.05M |
September 30, 2017 | -36.48M |
June 30, 2017 | -20.61M |
March 31, 2017 | -0.375M |
December 31, 2016 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-6.242M
Minimum
Mar 2022
31.25M
Maximum
Jun 2019
1.275M
Average
-3.63M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
Avinger Inc | -0.008M |
Fortress Biotech Inc | -2.103M |
AIM ImmunoTech Inc | -0.832M |
Protalix BioTherapeutics Inc | -16.71M |
Armata Pharmaceuticals Inc | -8.134M |